Focus
View

REGENERON PHARMACEUTICALS, INC.

REGN · FY2025

ALIGNED

CEO Package

$7.3M

Pay Ratio

—

Leonard S. Schleifer

Returns outran pay growth by +20.5 pts

ELI LILLY & Co

LLY · FY2025

ALIGNED

CEO Package

$30.2M

Pay Ratio

—

David A. Ricks

Returns outran pay growth by +3.5 pts

JOHNSON & JOHNSON

JNJ · FY2025

ALIGNED

CEO Package

$32.8M

Pay Ratio

—

J. Duato

Returns outran pay growth by +16.0 pts

CEOTotal Compensation — All Companies

REGN$7.3MLLY$30.2MJNJ$32.8M

All values are grant-date fair value as reported in proxy statements.

Key Differences

The fastest way to read this comparison before dropping into the tables.

JNJ carries the largest package at $32.8M, about 4.5x REGN.
LLY is the most equity-heavy package, while REGN leans hardest on non-equity incentive compensation.

Pay Component Breakdown

Latest CEO package mix by company. This stays on the CEO package even if the chart above is showing Top 5 pay.

REGN

Leonard S. Schleifer

$7.3M

base salary27%
non-equity incentive compensation51%
other compensation22%

LLY

David A. Ricks

$30.2M

base salary6%
stock awards77%
other compensation2%

JNJ

J. Duato

$32.8M

base salary5%
stock awards46%
option awards18%
non-equity incentive compensation13%
other compensation2%

Quick Comparison

CompanyCEOLatest YearTotal Comp
REGENERON PHARMACEUTICALS, INC.(REGN)Leonard S. Schleifer2025$7.3M
ELI LILLY & Co(LLY)David A. Ricks2025$30.2M
JOHNSON & JOHNSON(JNJ)N/A2025N/A

Note: All compensation values shown are grant-date fair value as reported in proxy statements. Direct comparisons should account for differences in company size, industry, and compensation structure.

Want to know when these numbers change?

We’ll email you when these companies file a new proxy — so you can see how CEO pay, equity awards, and ratios shift before the next headline.